Dong-A seeks to supply cycloserine to WHO agencies

Published: 2012-11-28 06:59:00

Updated: 2012-11-28 06:59:00

Dong-A has obtained a prequalification approval from the World Health Organization (WHO) for its multidrug-resistant tuberculosis (MDR-TB) drug, Closerin (cycloserine), Korea’s leading drug maker said on Monday.

A company spokesman said Dong-A has become Korea’s first drug producer to win the ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK